| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Irinotecan | gCSI | pan-cancer | AAC | -0.14 | 0.007 |
| mRNA | XMD14-99 | GDSC1000 | pan-cancer | AAC | 0.086 | 0.007 |
| mRNA | lapatinib | CCLE | pan-cancer | AAC | 0.12 | 0.008 |
| mRNA | CH5424802 | GDSC1000 | pan-cancer | AAC | 0.086 | 0.009 |
| mRNA | canertinib | CTRPv2 | pan-cancer | AAC | 0.093 | 0.009 |
| mRNA | SB-525334 | CTRPv2 | pan-cancer | AAC | 0.091 | 0.01 |
| mRNA | BRD-K16130065 | CTRPv2 | pan-cancer | AAC | 0.17 | 0.01 |
| mRNA | WZ4002 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.02 |
| mRNA | nelarabine | CTRPv2 | pan-cancer | AAC | 0.091 | 0.02 |
| mRNA | Rapamycin | gCSI | pan-cancer | AAC | -0.12 | 0.02 |